The Harms of Constructing Addiction as a Chronic, Relapsing Brain Disease

Affiliations

¹ Anne K. Lie and Isa Dussauge are with the Department of Community Medicine and Global Health, University of Oslo, Norway. Helena Hansen is with the Department of Psychiatry and with Research Theme in Health Equity and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. David Herzberg is with the Department of History, University at Buffalo, State University of New York. Alex Mold is with the Centre for History in Public Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. Marie Jauffret-Roustide is with the Center for the Study of Social Movements (CNRS UMR 8044/INSERM U1276/EHESS) in Paris, France and with the Baldy Center for Law and Social Policy, University at Buffalo. Samuel K. Roberts is with the Departments of History and Sociomedical Sciences, Columbia University, New York, NY. Jeremy Greene is with the Department of the History of Medicine and the Center for Medical Humanities and Social Medicine at Johns Hopkins University School of Medicine, Baltimore, MD. Nancy Campbell is with the Department of Science and Technology Studies, Rensselaer Polytechnic Institute, Troy, NY. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue.

Editorial

Anne K Lie et al. Am J Public Health. 2022 Apr.

. 2022 Apr;112(S2):S104-S108.

doi: 10.2105/AJPH.2021.306645.

¹ Anne K. Lie and Isa Dussauge are with the Department of Community Medicine and Global Health, University of Oslo, Norway. Helena Hansen is with the Department of Psychiatry and with Research Theme in Health Equity and Translational Social Science, David Geffen School of Medicine, University of California, Los Angeles. David Herzberg is with the Department of History, University at Buffalo, State University of New York. Alex Mold is with the Centre for History in Public Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. Marie Jauffret-Roustide is with the Center for the Study of Social Movements (CNRS UMR 8044/INSERM U1276/EHESS) in Paris, France and with the Baldy Center for Law and Social Policy, University at Buffalo. Samuel K. Roberts is with the Departments of History and Sociomedical Sciences, Columbia University, New York, NY. Jeremy Greene is with the Department of the History of Medicine and the Center for Medical Humanities and Social Medicine at Johns Hopkins University School of Medicine, Baltimore, MD. Nancy Campbell is with the Department of Science and Technology Studies, Rensselaer Polytechnic Institute, Troy, NY. Helena Hansen and Marie Jauffret-Roustide are also Guest Editors of this supplement issue.

No abstract available

References

1. Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 2021;46(10):1715–1723. doi: 10.1038/s41386-020-00950-y. - DOI - PMC - PubMed
1. Hammer R, Dingel M, Ostergren J, Partridge B, McCormick J, Koenig BA. Addiction: current criticism of the brain disease paradigm. AJOB Neurosci. 2013;4(3):27–32. doi: 10.1080/21507740.2013.796328. - DOI - PMC - PubMed
1. Room R. No level has primacy in what is called addiction: “addiction is a social disease” would be just as tenable. Neuropsychopharmacology. 2021;46(10):1712. doi: 10.1038/s41386-021-01015-4. - DOI - PMC - PubMed
1. Heather N, Best D, Kawalek A, et al. Challenging the brain disease model of addiction: European launch of the Addiction Theory Network. Addict Res Theory. 2018;26(4):249–255. doi: 10.1080/16066359.2017.1399659. - DOI
1. Hall W, Carter A, Forlini C. Brain disease model of addiction: misplaced priorities? Lancet Psychiatry. 2015;2(10):867. doi: 10.1016/S2215-0366(15)00417-4. - DOI - PubMed